Navigation Links
Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology
Date:2/15/2012

please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the future use and adoption of the CHEMOSAT system by the European Institute of Oncology, uncertainties relating to future initial launch and training agreements with other cancer centers in Europe, CE Marking for the Generation Two system and the timing of our commercial launch in Europe, the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and th
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 Auxilium ... specialty biopharmaceutical company, today announced that its Board ... non-binding and conditional proposal from Endo International plc ... and legal advisors, has unanimously determined it is ... its existing merger agreement with QLT Inc. ("QLT") ...
(Date:9/20/2014)... /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in consultation ... Mylan-Nitro Spray 0.4 mg/metered dose due to the product missing ... A missing "dip tube" could pose a ... This defect may lead patients to believe they are receiving ... it. Not receiving nitroglycerin could place them at risk for ...
(Date:9/19/2014)... 19, 2014 A pharmaceutical executive in the ... three issues he wanted the research and consulting firm ... personnel (especially for secondary research) to maximize efficiency and ... increased workload , Automation of market research processes ... , How to implement and manage those automated systems ...
Breaking Medicine Technology:Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2
... The complex cases performed,during this month,s ... Das, an interventional cardiologist at Presbyterian,Hospital of ... vascular,disease, a looming health concern as the ... heart disease. The country,s obesity epidemic will ...
... Calif., Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ... radiosurgery,announced today that the company is partnering with ... in Houston, Texas to launch a prospective,clinical study ... Patients in the study will be randomly assigned ...
Cached Medicine Technology:Cardiologists Tackle 'Next Frontier' in Cardiovascular Disease 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4
(Date:9/22/2014)... Pain does not need to rule your life ... reader-friendly book designed to guide the individual who suffers with ... book is written to help the reader who is struggling ... regain a pain-free life — a daily “go-to” guide on ... pain has become an epidemic, with over 100 million Americans ...
(Date:9/22/2014)... YORK (September 22, 2014) Montefiore Medical Center, Albert Einstein ... Women,s Hospital have received a $300,000 grant from The ... the impact of health Information Technology (IT) on patient ... electronic orders, an important clinical patient safety issue impacted ... will be the first time IT leaders have data ...
(Date:9/22/2014)... of flavonoid found in hops and beer, has been ... in young mice, but not in older animals. , ... Research by scientists from the Linus Pauling Institute ... It,s another step toward understanding, and ultimately reducing the ... mammalian species, including humans. , Flavonoids are compounds found ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Medical ... for a three-day conference to discuss brain-related diseases ... injury from concussions and neurodegenerative disorders. , ... director affiliated with a Silverado memory care community ... dedicated expertise in memory care, hosts the annual ...
(Date:9/22/2014)... North Carolina at Chapel Hill researchers represents an important ... are experiencing the earliest stages of psychosis. , Psychosis ... severe mental disorders such as schizophrenia. Schizophrenia emerges in ... in every 100 people. In severe cases, the impact ... and the burden on family members can be almost ...
Breaking Medicine News(10 mins):Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:AHRQ grant awarded to study the impact of health IT on patient safety at Montefiore and Einstein and Brigham and Women's Hospital 2Health News:Compound from hops aids cognitive function in young animals 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:Blood test may help determine who is at risk for psychosis 2
... -CTA Acceptance in the Netherlands Triggers Milestone Payment ... Radius Health ("Radius"),announced today that the Dutch regulatory ... RAD1901, Radius, novel,tissue-selective SERM (selective estrogen receptor modulator) ... to begin a Phase I,clinical trial of RAD1901 ...
... Thanks to Nutrition on the Go, an,innovative new program ... more than 1,700 restaurants nationwide is available in,a flash through ... and menu item., Not cell phone savvy? No worries. ... menu item you need help with, then send that info ...
... LANCASTER, Pa., Jan. 30 Members of Highmark,s,FreedomBlue ... care options. Effective immediately, both routine and emergency,medical ... and Lancaster,Regional hospitals., "We,re pleased to partner ... and high-quality health care to people with Medicare ...
... CHESTER, N.J. and SLOUGH, England, Jan. 30 ... the,successful completion of its acquisition of Adams Respiratory ... cash tender offer followed by a,short- form merger ... and into Adams. As a result of this ...
... (OTC Bulletin,Board: NTRZ) announced today that it has filed ... U.S. Securities and Exchange,Commission (SEC). If and when declared ... offer and sell under the universal shelf registration,statement up ... preferred,stock, depositary shares and/or warrants to purchase any of ...
... Jan. 30 EMH Regional Healthcare System has,selected ... increasing bad debt and streamline administration of its ... is a 434-bed, non-profit hospital,system with campuses in ... the,EMH Regional Healthcare System has served the needs ...
Cached Medicine News:Health News:Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 2Health News:Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes 3Health News:Ring Up Instant Nutrition Info via Text Message to DIET1 (34381) 2Health News:Heart of Lancaster and Lancaster Regional Join Highmark Blue Shield Medicare Advantage Network 2Health News:Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc. 2Health News:NutraCea Files Universal Shelf Registration Statement 2Health News:EMH Regional Medical Center Selects TransUnion's Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 2Health News:EMH Regional Medical Center Selects TransUnion's Healthcare Revenue Cycle Platform to Help Reduce Its Bad Debt 3
... 150 watt halogen light ... , ,SOLOS Endoscopy shares ... patient with the highest quality ... research and development of advanced ...
... first for Linvatec! The EnVision Autoclavable ... and proprietary technology to ensure true ... Shockflex prism system gives our customers ... their investment. With an integrated multi-specialty ...
... surgery is founded on superior medical video ... 3-Chip cameras, 1-Chip cameras, Light sources, Couplers ... demanding needs., ,Superior resolution and color ... 3-Chip cameras, and are the benchmark by ...
... System provides easy-to-use features, auto iris, white ... camera head construction is based on Solos ... 1-Chip Camera System, Domestic (GS 9960-NTSC) includes: ... with power cord and video cables , ...
Medicine Products: